rs35794454

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_020750.3(XPO5):​c.2423C>T​(p.Ala808Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000804 in 1,604,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A808T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00017 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000071 ( 0 hom. )

Consequence

XPO5
NM_020750.3 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.17

Publications

4 publications found
Variant links:
Genes affected
XPO5 (HGNC:17675): (exportin 5) This gene encodes a member of the karyopherin family that is required for the transport of small RNAs and double-stranded RNA-binding proteins from the nucleus to the cytoplasm. The encoded protein translocates cargo through the nuclear pore complex in a RanGTP-dependent process. [provided by RefSeq, Aug 2011]
POLR1C (HGNC:20194): (RNA polymerase I and III subunit C) The protein encoded by this gene is a subunit of both RNA polymerase I and RNA polymerase III complexes. The encoded protein is part of the Pol core element. Mutations in this gene have been associated with Treacher Collins syndrome (TCS) and hypomyelinating leukodystrophy 11. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
POLR1C Gene-Disease associations (from GenCC):
  • hypomyelinating leukodystrophy 11
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Treacher Collins syndrome 3
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
  • Treacher-Collins syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018837959).
BS2
High AC in GnomAd4 at 26 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
XPO5NM_020750.3 linkc.2423C>T p.Ala808Val missense_variant Exon 21 of 32 ENST00000265351.12 NP_065801.1 Q9HAV4
XPO5NR_144392.2 linkn.2735C>T non_coding_transcript_exon_variant Exon 22 of 33
POLR1CNM_001363658.2 linkc.922+12879G>A intron_variant Intron 8 of 9 NP_001350587.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
XPO5ENST00000265351.12 linkc.2423C>T p.Ala808Val missense_variant Exon 21 of 32 1 NM_020750.3 ENSP00000265351.7 Q9HAV4

Frequencies

GnomAD3 genomes
AF:
0.000171
AC:
26
AN:
152124
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000883
AC:
22
AN:
249182
AF XY:
0.0000888
show subpopulations
Gnomad AFR exome
AF:
0.000258
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000556
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000885
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.0000709
AC:
103
AN:
1451936
Hom.:
0
Cov.:
30
AF XY:
0.0000748
AC XY:
54
AN XY:
722304
show subpopulations
African (AFR)
AF:
0.000482
AC:
16
AN:
33210
American (AMR)
AF:
0.000158
AC:
7
AN:
44398
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25862
East Asian (EAS)
AF:
0.0000255
AC:
1
AN:
39204
South Asian (SAS)
AF:
0.0000467
AC:
4
AN:
85660
European-Finnish (FIN)
AF:
0.0000191
AC:
1
AN:
52280
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5728
European-Non Finnish (NFE)
AF:
0.0000615
AC:
68
AN:
1105884
Other (OTH)
AF:
0.0000837
AC:
5
AN:
59710
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000171
AC:
26
AN:
152242
Hom.:
0
Cov.:
32
AF XY:
0.000188
AC XY:
14
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.000481
AC:
20
AN:
41554
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68000
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000141
Hom.:
0
Bravo
AF:
0.000212
ESP6500AA
AF:
0.000546
AC:
2
ESP6500EA
AF:
0.000123
AC:
1
ExAC
AF:
0.0000828
AC:
10
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 18, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2423C>T (p.A808V) alteration is located in exon 21 (coding exon 21) of the XPO5 gene. This alteration results from a C to T substitution at nucleotide position 2423, causing the alanine (A) at amino acid position 808 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
5.9
DANN
Benign
0.79
DEOGEN2
Benign
0.10
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.093
N
LIST_S2
Benign
0.77
T
M_CAP
Benign
0.0057
T
MetaRNN
Benign
0.019
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.34
N
PhyloP100
2.2
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.073
Sift
Benign
0.57
T
Sift4G
Benign
0.47
T
Polyphen
0.0020
B
Vest4
0.073
MVP
0.12
MPC
0.37
ClinPred
0.016
T
GERP RS
-1.6
Varity_R
0.063
gMVP
0.21
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35794454; hg19: chr6-43501664; API